Madrigal Pharmaceuticals Inc’s recent filing unveils that its Officer Mardi Dier acquired Company’s shares for reported $0.39 million on Mar 03 ’25. In the deal valued at $325.89 per share,1,187 shares were bought.
Then, SHANNON KELLEY bought 415 shares, generating $141,627 in total proceeds.
Before that, CAROLE A HUNTSMAN bought 1,834 shares. Madrigal Pharmaceuticals Inc shares valued at $625,889 were divested by the Officer at a price of $341.27 per share.
B. Riley Securities upgraded its Madrigal Pharmaceuticals Inc [MDGL] rating to a Buy from a a Neutral in a research note published on February 28, 2025; the price target was increased to $422 from $236. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who remained covering the stock and in late February has reiterated a ‘”a Buy”‘ rating for it. Cantor Fitzgerald began covering MDGL with “Neutral” recommendation on June 28, 2024. Wolfe Research started covering the stock on June 11, 2024. It rated MDGL as “an Outperform”.
Price Performance Review of MDGL
On Monday, Madrigal Pharmaceuticals Inc [NASDAQ:MDGL] saw its stock fall -8.15% to $313.47. Over the last five days, the stock has lost -2.69%. Madrigal Pharmaceuticals Inc shares have risen nearly 1.59% since the year began. Nevertheless, the stocks have risen 23.30% over the past one year. While a 52-week high of $377.46 was reached on 02/26/25, a 52-week low of $189.00 was recorded on 01/15/25. SMA at 50 days reached $321.52, while 200 days put it at $277.12.
Levels Of Support And Resistance For MDGL Stock
The 24-hour chart illustrates a support level at 305.86, which if violated will result in even more drops to 298.25. On the upside, there is a resistance level at 328.24. A further resistance level may holdings at 343.01. The Relative Strength Index (RSI) on the 14-day chart is 45.14, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -6.24, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 93.96%. Stochastics %K at 30.55% indicates the stock is a holding.
The most recent change occurred on April 22, 2024 when BofA Securities began covering the stock and recommended ‘”an Underperform”‘ rating along with a $150 price target.
